A Hyaluronidase-Responsive Nanoparticle-Based Drug Delivery System for Targeting Colon Cancer Cells.
Zhang, Mingzhen; Xu, Changlong; Wen, Liuqing; Han, Moon Kwon; Xiao, Bo; Zhou, Jun; Zhang, Yuchen; Zhang, Zhan; Viennois, Emilie; Merlin, Didier.
; 76(24): 7208-7218, 2016 12 15.
Artigo em Inglês | MEDLINE | ID: mdl-27742685
Bioresponsive hyaluronic acid-capped mesoporous silica nanoparticles for targeted drug delivery.
Biotin Decorated Gold Nanoparticles for Targeted Delivery of a Smart-Linked Anticancer Active Copper Complex: In Vitro and In Vivo Studies.
Combination therapy of paclitaxel and cyclopamine polymer-drug conjugates to treat advanced prostate cancer.
Size-dependent tumor penetration and in vivo efficacy of monodisperse drug-silica nanoconjugates.
The duration of hyaluronidase and optimal timing of hyaluronic acid (HA) filler reinjection after hyaluronidase injection.
Pamidronate functionalized nanoconjugates for targeted therapy of focal skeletal malignant osteolysis.
Quantitative Correlation Between Hyaluronic Acid Filler and Hyaluronidase.
Nanoparticle delivered vascular disrupting agents (VDAs): use of TNF-alpha conjugated gold nanoparticles for multimodal cancer therapy.
Small conjugate-based theranostic agents: an encouraging approach for cancer therapy.
Calibration-quality cancer nanotherapeutics.